Andrew Kaiser
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 46
- CAR-T cell therapy research 44
- Immunology 32
- Immunotherapy and Immune Responses 22
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 12
- Co-authors
- Nicholas P. Restifo (11 shared papers)Chrystal M. Paulos (10 shared papers)Luca Gattinoni (9 shared papers)Douglas C. Palmer (8 shared papers)Claudia Wrzesinski (8 shared papers)Pawel Muranski (8 shared papers)Steven A. Rosenberg (8 shared papers)Christian S. Hinrichs (6 shared papers)
- Journals
- Blood (8 papers)Journal for ImmunoTherapy of Cancer (5 papers)The Journal of Immunology (5 papers)Cancer Immunology Immunotherapy (4 papers)Human Gene Therapy (4 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Andrew Kaiser
56 papers receiving 4.2k citations
Andrew Kaiser's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 3.0k
- Immunology 2.4k
- Genetics 798
- Molecular Biology 1.1k
- Biotechnology 105
Countries citing papers authored by Andrew Kaiser
This map shows the geographic impact of Andrew Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kaiser more than expected).
Fields of papers citing papers by Andrew Kaiser
This network shows the impact of papers produced by Andrew Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kaiser. The network helps show where Andrew Kaiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-specific Th17-polarized cells eradicate large established melanoma Hit paper breakdown → | 2008 | 642 |
| 2 | 2007 | 457 | |
| 3 | 2010 | 327 | |
| 4 | 2009 | 212 | |
| 5 | 2010 | 207 | |
| 6 | 2017 | 204 | |
| 7 | 2010 | 195 | |
| 8 | 2016 | 170 | |
| 9 | 2009 | 163 | |
| 10 | 2007 | 153 | |
| 11 | 2018 | 122 | |
| 12 | 2008 | 116 | |
| 13 | 2007 | 104 | |
| 14 | 2006 | 100 | |
| 15 | 2015 | 95 | |
| 16 | 2017 | 87 | |
| 17 | 2005 | 77 | |
| 18 | 2011 | 77 | |
| 19 | 2017 | 53 | |
| 20 | 2018 | 52 |
About Andrew Kaiser
Andrew Kaiser is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 56 papers that have together received 4.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (44 papers), Immunotherapy and Immune Responses (22 papers), Immune Cell Function and Interaction (18 papers), Viral Infectious Diseases and Gene Expression in Insects (14 papers), Virus-based gene therapy research (13 papers), T-cell and B-cell Immunology (12 papers), Nanowire Synthesis and Applications (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (2.4k citations), Genetics (798 citations), Molecular Biology (1.1k citations) and Biotechnology (105 citations). Andrew Kaiser has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Nicholas P. Restifo, Chrystal M. Paulos, Luca Gattinoni, Douglas C. Palmer, Claudia Wrzesinski, Pawel Muranski, Steven A. Rosenberg, Christian S. Hinrichs, Zhiya Yu and Lydie Cassard. Their work appears in journals such as Blood, Journal for ImmunoTherapy of Cancer, The Journal of Immunology, Cancer Immunology Immunotherapy and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.